Tuesday, 1 March 2022

Reuters Global Healthcare: Inovio says COVID vaccine shows robust T-cell response against Omicron in lab tests

Inovio says COVID vaccine shows robust T-cell response against Omicron in lab tests

Inovio Pharmaceuticals Inc said on Tuesday its lead COVID-19 vaccine candidate maintained robust T-cell responses against the Omicron variant, but showed decreased levels of both neutralizing and binding antibodies in lab testing.

Warren, 12 other U.S. lawmakers press drugs lobby group on price increases

Senators Elizabeth Warren and Amy Klobuchar and 11 other U.S. lawmakers pressed the president of the biggest pharmaceutical industry trade group on Tuesday about what they said were "troubling price increases for brand name drugs" in January.

Britain revokes mandatory COVID shots for health workers

Britain on Tuesday confirmed that a requirement for health workers to have a COVID-19 vaccination would no longer be introduced in April and care home workers would no longer be required to have the shots from March 15.

Germany pledges more funds for COVID vaccines in poor countries

Germany will provide a further $1.5 billion to a global initiative for better access to coronavirus vaccines for poorer countries, Finance Minister Christian Lindner said on Tuesday.

Biden to announce U.S. strategy to address mental health -White House

U.S. President Joe Biden will lay out a strategy to address the nation's "unprecedented mental health crisis" in his State of the Union speech on Tuesday night, the White House said in a statement.

AstraZeneca, Swiss firm Neurimmune ink $760 million deal for antibody drug

AstraZeneca Plc has agreed to develop an antibody-based therapy with Swiss biotechnology firm Neurimmune for a rare, underdiagnosed condition that can lead to heart failure in a deal valued up to $760 million, the drugmaker said on Tuesday.

U.S. FDA declines to approve Gilead's HIV drug on glass vial concerns

The U.S health regulator has declined to approve Gilead Sciences' injectable drug for the treatment of HIV-1 infection over concerns related to the vials meant for the drug, the company said on Tuesday.

What you need to know about the coronavirus right now

Here's what you need to know about the coronavirus right now:

Pfizer's bacterial infection vaccine fails main goal in study

Pfizer Inc said on Tuesday its vaccine to prevent infections from a bacteria that mainly spreads through hospitals and doctors' offices and can even prove fatal, failed to meet the main goal of a late-stage study.

Dutch to cull around 84,000 chickens after bird flu detected

Around 47,000 chickens on a farm in the eastern Dutch city of Wageningen will be culled after the detection of highly infectious bird flu, the government said on Tuesday.

Related Videos

Making heart health a priority for Black women

AstraZeneca shelf life hurts rollout for world's poorest

Easing COVID curbs could cause 2 mln deaths: China study